Gene · 1195
Papers1,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of Safety and Efficacy of a Single Lorecivivint Injection in Patients with Knee Osteoarthritis: A Multicenter, Observational Extension Trial. | Rheumatol Ther | 2025 | 39755925 | PubTator, text mining | PubMed |
| CLK1 Activates YAP to Promote Intrahepatic Cholangiocarcinogenesis. | Cancer Res | 2025 | 39693605 | PubTator, text mining | PubMed |
| Effect of reduced flaxseed cyclic peptide [1-9-NαC]-linusorb B2 (CLB) and its oxidized form on the oxidative stability of flaxseed oil. | Food Chem | 2025 | 39561593 | PubTator, text mining | PubMed |
| Proteomic study identifies Aurora-A-mediated regulation of alternative splicing through multiple splicing factors. | J Biol Chem | 2025 | 39551136 | PubTator, text mining | PubMed |
| Impact of structural severity on outcomes in knee osteoarthritis: an analysis of data from phase 2 and phase 3 lorecivivint clinical trials. | Rheumatology (Oxford) | 2025 | 39495154 | PubTator, text mining | PubMed |
| Design, synthesis, and structure-activity relationship studies of 6H-benzo[b]indeno[1,2-d]thiophen-6-one derivatives as DYRK1A/CLK1/CLK4/haspin inhibitors. | RSC Med Chem | 2025 | 39430953 | PubTator, text mining | PubMed |
| Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression. | Mol Oncol | 2025 | 39258426 | PubTator, text mining | PubMed |
| Characterization of aberrant splicing in pediatric central nervous system tumors reveals CLK1 as a candidate oncogenic dependency. | bioRxiv | 2025 | 39149264 | PubTator, text mining | PubMed |
| Phosphodiesterase 9 localization in cytoplasm and nucleus: the gateway to selective targeting in neuroprotection? | Neural Regen Res | 2025 | 39104101 | PubTator, text mining | PubMed |
| Real-Time Monitoring Method and Circuit Based on Built-In Reliability Prediction. | Micromachines (Basel) | 2024 | 39858659 | PubTator, text mining | PubMed |
| Boronic Acid-Containing 3H- pyrazolo[4,3-f]quinoline Compounds as Dual CLK/ROCK Inhibitors with Anticancer Properties. | Pharmaceuticals (Basel) | 2024 | 39770502 | PubTator, text mining | PubMed |
| Machine learning-based selection of immune cell markers in osteosarcoma: prognostic determination and validation of CLK1 in disease progression. | Front Immunol | 2024 | 39742274 | PubTator, text mining | PubMed |
| Novel parallel inputs shift registers with set/reset terminals in QCA nanotechnology. | Heliyon | 2024 | 39654731 | PubTator, text mining | PubMed |
| Cell modeling using frequency modulation. | PLoS One | 2024 | 39642158 | PubTator, text mining | PubMed |
| Novel Thiazole-Fused [4,5-g] or [5,4-g]Quinazolin-8-ones and Their Quinazoline Analogues: Synthesis and Biological Evaluation. | Pharmaceuticals (Basel) | 2024 | 39598364 | PubTator, text mining | PubMed |
| Regulatory interplay between SR proteins governs CLK1 kinase splice variants production. | RNA | 2024 | 39251328 | PubTator, text mining | PubMed |
| Thermoregulated transcriptomics: the molecular basis and biological significance of temperature-dependent alternative splicing. | Biochem J | 2024 | 39083035 | PubTator, text mining | PubMed |
| Review of Integrated Gate Driver Circuits in Active Matrix Thin-Film Transistor Display Panels. | Micromachines (Basel) | 2024 | 39064334 | PubTator, text mining | PubMed |
| N-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer Agents. | Cancers (Basel) | 2024 | 38893153 | PubTator, text mining | PubMed |
| Genome-wide association study identifies novel susceptible loci and evaluation of polygenic risk score for chronic obstructive pulmonary disease in a Taiwanese population. | BMC Genomics | 2024 | 38886662 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1195/papers?page=5